Comparison of Patients with Community-Acquired Pneumonia Who Did and Did not Receive Treatment in Accordance with the 2009 Pneumonia Guideline of Turkish Thoracic Society

被引:3
|
作者
Soylar, Oznur Kilic [1 ]
Kilinc, Oguz [1 ]
Ellidokuz, Hulya [2 ]
机构
[1] Dokuz Eylul Univ, Fac Med, Dept Chest Dis, Izmir, Turkey
[2] Dokuz Eylul Univ, Biostat Discipline, Dept Prevent Oncol, Izmir, Turkey
关键词
Community-acquired pneumonia; pneumonia treatment guideline; adherence with guideline;
D O I
10.5152/ttd.2015.4437
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
OBJECTIVES: The purpose of our study was to compare community-acquired pneumonia (CAP) patients who were and were not administered treatment in accordance with the Turkish Thoracic Society (TTS) 2009 pneumonia guideline in terms of hospital stay length, treatment cost, and treatment efficacy. MATERIAL AND METHODS: Patients who were admitted to our hospital and who were diagnosed with CAP were included in the study. Demographic characteristics of the patients, symptoms at the time of diagnosis, physical examination, laboratory and radiological findings, treatments, response to treatment at follow-up, length of hospital stay, and direct cost of treatment were recorded in the TTS pneumonia database (TURCAP: TURKEY Community Acquired Pneumonia). Taking into consideration the "Turkish Thoracic Society Consensus Report on the Diagnosis and Treatment of Community-acquired pneumonia in Adults (2009)," the patients recorded in the database were evaluated in terms of conformity to the guideline. RESULTS: This present study included 156 patients diagnosed with CAP. Sixty-six patients (42.3%) were females, and 96 (57.7%) were males, and the mean age of the patients was 70.4 years. The most common symptoms on admission were cough (94.9%), expectoration of purulent sputum (77.6%), and fever (58%). Comorbid diseases were chronic obstructive pulmonary disease (COPD; 29.5%), asthma (3.2%), lung cancer (8.3%), cardiovascular diseases (32.7%), and diabetes mellitus (12.8%). It was observed that 67.3% of the patients received treatment in accordance with the guideline. No significant difference was found in terms of gender and symptoms between the groups that received and did not receive treatment in accordance with the guideline. The mean age of the patients who received treatment according to the guideline was higher than that of the patients who did not receive treatment according to the guideline; COPD was more frequent in the group of patients who received treatment according to the guideline. Pneumonia Severity Index and Confusion, Urea, Respiratory rate, Blood pressure-Age>65 scores of the patients who were treated according to the guideline was higher and treatment resulted in death in 8% of these patients. CONCLUSION: Hospital stay length, treatment cost, and treatment efficacy were similar in patients who were and were not administered treatment in accordance with the guideline.
引用
收藏
页码:64 / 67
页数:4
相关论文
共 50 条
  • [41] Accordance of Registered Drug Packages with Guideline-Recommended Treatment Durations for Community-Acquired Pneumonia-A New Antibiotic Stewardship Target?
    Prusac, Martina
    Hadziabdic, Maja Ortner
    Rusic, Doris
    Modun, Darko
    ANTIBIOTICS-BASEL, 2024, 13 (06):
  • [42] Comparison of inflammation markers with prediction scores in patients with community-acquired pneumonia
    Acar, E.
    Gokcen, H.
    Demir, A.
    Yildirim, B.
    BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY, 2021, 122 (06): : 418 - 423
  • [43] Community-acquired pneumonia in patients admitted to National District Hospital in Bloemfontein: guideline adherence
    Ford, Thornton
    Potgieter, Johane
    Van der Walt, Jana
    Van Schalkwyk, Monette
    Van Lill, Maresa
    Joubert, Gina
    SOUTH AFRICAN FAMILY PRACTICE, 2018, 60 (06) : 214 - 215
  • [44] Guideline-concordant antimicrobial therapy and mortality in patients with community-acquired pneumonia.
    Mortensen, E
    Restrepo, M
    Anzueto, A
    Pugh, J
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2003, 18 : 226 - 227
  • [45] SEVERE PNEUMONIA IN CANCER PATIENTS: CLINICAL OUTCOMES AND A COMPARISON BETWEEN HEALTHCARE-ASSOCIATED PNEUMONIA AND COMMUNITY-ACQUIRED PNEUMONIA
    Rabello, L.
    Soares, M.
    Azevedo, L.
    Lapa e Silva, J. R.
    Souza, I. A.
    Salluh, J.
    INTENSIVE CARE MEDICINE, 2013, 39 : S329 - S329
  • [46] Management of community-acquired pneumonia in children: South African Thoracic Society guidelines (part 3)
    Reubenson, G.
    Avenant, T.
    Moore, D. P.
    Itzikowitz, G.
    Andronikou, S.
    Cohen, C.
    Green, R. J.
    Jeena, P.
    Masekela, R.
    Nicol, M. P.
    Pillay, A.
    Madhi, S. A.
    Zar, H. J.
    Argent, A. C.
    SAMJ SOUTH AFRICAN MEDICAL JOURNAL, 2020, 110 (08): : 734 - 740
  • [47] Diagnosis of community-acquired pneumonia in children: South African Thoracic Society guidelines (part 2)
    Zar, H. J.
    Moore, D. P.
    Itzikowitz, G.
    Green, R. J.
    Argent, A. C.
    Avenant, T.
    Cohen, C.
    Jeena, P.
    Masekela, R.
    Pillay, A.
    Reubenson, G.
    Madhi, S. A.
    Andronikou, S.
    Nicol, M. P.
    SAMJ SOUTH AFRICAN MEDICAL JOURNAL, 2020, 110 (07): : 588 - 593
  • [48] British Thoracic Society community-acquired pneumonia care bundle: results of a national implementation project
    Lim, Wei Shen
    Rodrigo, Chamira
    Turner, Alice M.
    Welham, Sally
    Calvert, James M.
    THORAX, 2016, 71 (03) : 288 - +
  • [49] Assessment of prognosis in patients with community-acquired pneumonia who require mechanical ventilation
    Pascual, FE
    Matthay, MA
    Bacchetti, P
    Wachter, RM
    CHEST, 2000, 117 (02) : 503 - 512
  • [50] Prevention of community-acquired pneumonia in children: South African Thoracic Society guidelines (part 4)
    Zar, H. J.
    Moore, D. P.
    Andronikou, S.
    Argent, A. C.
    Avenant, T.
    Cohen, C.
    Green, R. J.
    Itzikowitz, G.
    Jeena, P.
    Nicol, M. P.
    Pillay, A.
    Reubenson, G.
    Masekela, R.
    Madhi, S. A.
    SAMJ SOUTH AFRICAN MEDICAL JOURNAL, 2020, 110 (08): : 741 - 746